The attachment of tumor-released mesothelin to a GPI anchor was shown using a novel ELISA assay that detects soluble molecules bearing both a mesothelin epitope and GPI core glycan moieties, as well as by lipid profiling of mesothelin immunoprecipitated from tumor cell conditioned media. The gene discussed is MSLN; the disease is neoplasm.